WCG
AVXL icon

Weaver Consulting Group’s Anavex Life Sciences AVXL Stock Holding History

Weaver Consulting Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,796
Closed -$96.1K – 269
2025
Q3 		$96.1K Buy
10,796
+630
+6% +$6.39K 0.02% 262
2025
Q2 		$93.7K Buy
+10,166
New +$86.8K 0.03% 242

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Weaver Consulting Group's AVXL Position: Q4 2025 in Review

Weaver Consulting Group sold out of Anavex Life Sciences (AVXL) in Q4 2025, closing a stake of 10,796 shares — an estimated $96.1K sold.

Weaver Consulting Group first reported a position in AVXL in Q2 2025 and held it in 2 quarters. The position peaked at $96.1K in Q3 2025. 184 funds tracked by Wall St. Rank hold AVXL as of Q4 2025.

  • Weaver Consulting Group reported no remaining Anavex Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Weaver Consulting Group sold 10,796 Anavex Life Sciences shares in Q4 2025, an estimated $96.1K.
  • Weaver Consulting Group first reported a position in Anavex Life Sciences in Q2 2025 and held it in 2 quarters.
  • Weaver Consulting Group's Anavex Life Sciences position peaked at $96.1K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2025.

Based on Weaver Consulting Group's 13F filing for Q4 2025, filed 10 Feb 2026.